Apoptosis induction by glycoprotein isolated from Laminaria japonica is associated with down-regulation of telomerase activity and prostaglandin E 2 synthesis in AGS human gastric cancer cells

International Journal of Oncology

Volumn 38, Issue 2, 2011, Pages 577-584

  Han, Min Ho ^a   Kim, Gi Young ^b   Moon, Sung Kwon ^c,e   Kim, Wun Jae ^d,e   Nam, Taek Jeong ^f   Choi, Yung Hyun ^a,e,g  

^a Dong Eui University   (South Korea)

^b Jeju National University   (South Korea)

^c Chungju National University   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e Chungbuk National University   (South Korea)

^f Pukyong National University   (South Korea)

^g Dong Eui University   (South Korea)

Author keywords

Apoptosis; COX 2; Glycoprotein; Laminaria japonica; Telomerase

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLYCOPROTEIN; MYC PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROSTAGLANDIN E2; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; LAMINARIA; LAMINARIA JAPONICA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STOMACH CANCER; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; DOWN-REGULATION; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; LAMINARIA; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TELOMERASE;

EID: 78651249050     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.853     Document Type: Article

References (45)

1. Khan N, Adhami VM and Mukhtar H: Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76: 1333-1339, 2008.
2. Burz C, Berindan-Neagoe I, Balacescu O and Irimie A: Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48: 811-821, 2009.
3. Brenner D and Mak TW: Mitochondrial cell death effectors. Curr Opin Cell Biol 21: 871-877, 2009.
4. Jeong SY and Seol AW: The role of mitochondria in apoptosis. BMB Rep 41: 11-22, 2008.
5. Mellier G, Huang S, Shenoy K and Pervaiz S: TRAILing death in cancer. Mol Aspects Med 31: 93-112, 2010.
6. Artandi SE and De Pinho RA: Telomeres and telomerase in cancer. Carcinogenesis 31: 9-18, 2010.
7. Harrington L: Biochemical aspects of telomerase function. Cancer Lett 194: 139-154, 2003.
8. Hahn WC and Meyerson M: Telomerase activation, cellular immortalization and cancer. Ann Med 33: 123-129, 2001.
9. Incles CM, Schultes CM and Neidle S: Telomerase inhibitors in cancer therapy: current status and future directions. Curr Opin Investig Drugs 4: 675-685, 2003.
10. Clària J and Romano M: Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr Pharm Des 11: 3431-3447, 2005.
11. Wang MT, Honn KV and Nie D: Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534, 2007.
12. Tiguert R, Lessard A, So A and Fradet Y: Prognostic markers in muscle invasive bladder cancer. World J Urol 20: 190-195, 2002.
13. Kashfi K and Rigas B: Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochem Pharmacol 70: 969-986, 2005.
14. Hull MA: Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur J Cancer 41: 1854-1863, 2005.
15. Aparicio Gallego G, Díaz Prado S, Jiménez Fonseca P, García Campelo R, Cassinello Espinosa J and Antón Aparicio LM: Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer. Clin Transl Oncol 9: 694-702, 2007.
16. Hocman G: Prevention of cancer: vegetables and plants. Comp Biochem Physiol B 93: 201-212, 1989.
17. Harris PJ and Ferguson LR: Dietary fibre: its composition and role in protection against colorectal cancer. Mutat Res 290: 97-110, 1993.
18. Yamori Y, Miura A and Taira K: Implications from and for food cultures for cardiovascular diseases: Japanese food, particularly Okinawan diets. Asia Pac J Clin Nutr 10: 144-145, 2001.
19. Smyth P, Cloughley G, Clarke C, Smith D and Burbridge E: Iodine and differentiated thyroid cancer: pathogenetic and therapeutic implications. Hormones 8: 192-198, 2009.
20. Teas J: The dietary intake of Laminaria, a brown seaweed, and breast cancer prevention. Nutr Cancer 4: 217-222, 1982.
21. Phaneuf D, Côté I, Dumas P, Ferron LA and LeBlanc A: Evaluation of the contamination of marine algae (Seaweed) from the St. Lawrence River and likely to be consumed by humans. Environ Res 80: S175-S182, 1999.
22. Lee NY, Ermakova SP, Zvyagintseva TN, Kang KW, Dong Z and Choi HS: Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells. Food Chem Toxicol 46: 1793-1800, 2008.
23. Wang J, Wang F, Zhang Q, Zhang Z, Shi X and Li P: Synthesized different derivatives of low molecular fucoidan extracted from Laminaria japonica and their potential antioxidant activity in vitro. Int J Biol Macromol 44: 379-384, 2009.
24. Nagamine T, Hayakawa K, Kusakabe T, Takada H, Nakazato K, Hisanaga E and Iha M: Inhibitory effect of fucoidan on Huh7 hepatoma cells through downregulation of CXCL12. Nutr Cancer 61: 340-347, 2009.
25. Huang L, Wen K, Gao X and Liu Y: Hypolipidemic effect of fucoidan from Laminaria japonica in hyperlipidemic rats. Pharm Biol 48: 422-426, 2010.
26. Zhu Z, Zhang Q, Chen L, Ren S, Xu P, Tang Y and Luo D: Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation. Thromb Res 125: 419-426, 2010.
27. Cho DM, Kim DS, Lee DS, Kim HR and Pyeun JH: Trace components and functional saccharides in seaweed-1. Changes in proximate composition and trace elements according to the harvest season and places. Bull Kor Fish Soc 28: 49-59, 1995.
28. Go H, Hwang HJ and Nam TJ: Glycoprotein extraction from Laminaria japonica promotes IEC-6 cell proliferation. Int J Mol Med 24: 819-824, 2009.
29. Go H, Hwang HJ and Nam TJ: A glycoprotein from Laminaria japonica induces apoptosis in HT-29 colon cancer cells. Toxicol In Vitro 24: 1546-1553, 2010.
30. Jang KJ, Han MH, Lee BH, Kim BW, Kim CH, Yoon HM and Choi YH: Induction of apoptosis by ethanol extracts of Ganoderma lucidum in human gastric carcinoma cells. J Acupunct Meridian Stud 3: 24-31, 2010.
31. Lee W, Choi HI, Kim MJ and Park SY: Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability. Exp Mol Med 40: 109-117, 2008.
32. Moon DO, Kim MO, Kang CH, Lee JD, Choi YH and Kim GY: JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosis. Exp Mol Med 41: 665-677, 2009.
33. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985, 1993.
34. De Graaf AO, De Witte T and Jansen JH: Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? Leukemia 18: 1751-1759, 2004.
35. Ito H, Kyo S, Kanaya T, Takakura M, Inoue M and Namiki M: Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 4: 1603-1608, 1998. (Pubitemid 28304720)
36. Kyo S, Takakura M, Fujiwara T and Inoue M: Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99: 1528-1538, 2008.
37. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE and Oltvai ZN: Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327-332, 1993.
38. Earnshaw WC, Martins LM and Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 6: 383-424, 1996.
39. Stennicke HR and Salvesen GS: Properties of the caspases. Biochim Biophys Acta 1387: 17-31, 1998.
40. Pizzimenti S, Briatore F, Laurora S, Toaldo C, Maggio M, De Grandi M, Meaglia L, Menegatti E, Giglioni B, Dianzani MU and Barrera G: 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radic Biol 40: 1578-1591, 2008.
41. Cong YS, Wen J and Bacchetti S: The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8: 137-142, 1999.
42. Mandal M and Kumar R: Bcl-2 modulates telomerase activity. J Biol Chem 272: 14183-14187, 1997.
43. Fu W, Begley JG, Killen MW and Mattson MP: Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 274: 7264-7271, 1999.
44. Soh JW and Weinstein IB: Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog Exp Tumor Res 37: 261-285, 2003.
45. Gately S and Kerbel R: Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Prog Exp Tumor Res 37: 179-192, 2003.